Stevia First Corp. to Present in New York and Las Vegas in September

SACRAMENTO, CA--(Marketwired - Sep 8, 2014) - Stevia First Corp. (OTCQB: STVF) ("Stevia First" or the "Company"), an agricultural biotechnology company based in California's Central Valley growing region and focused on the industrial scale production of stevia, the all-natural zero-calorie sweetener that is rapidly transforming the food and beverage industry, is pleased to advise of upcoming presentations and availability for one-on-one meetings at two key investment and technology conferences in September.

In addition, and in preparation for the upcoming conferences, the Company wishes to provide immediate access to its updated corporate presentation which includes important details of Stevia First's recently announced exclusive distribution and licensing agreements with Qualipride International Ltd. The presentation is available for download on the www.steviafirst.com home page or at: http://bit.ly/1qCjbNo.

UPCOMING PRESENTATIONS:

Rodman and Renshaw 16th Annual Global Investment Conference
Robert Brooke, CEO of Stevia First will present a corporate overview of the company at the 16th Annual Rodman & Renshaw Global Investment Conference, taking place at the New York Palace Hotel in New York City, NY September 8-10, 2014. The presentation will be held on Wednesday, September 10th in the Kennedy II Salon (4th floor) at 10:50 AM ET. At the time of the presentation, a live webcast will be available via the following link: http://wsw.com/webcast/rrshq24/stvf

Stevia First recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. After the presentation, an archived version of the webcast will be available on the Stevia First website at www.steviafirst.com.

Rodman & Renshaw 2014 Annual Global Investment Conference will attract over 250 public and private companies from around the world to present to an audience of over 2,000 engaged attendees. The event will feature corporate presentations, Q&A sessions, 1-on-1 meetings and daily networking opportunities meant to facilitate discussions between institutional investors, venture capitalists, private equity firms, sophisticated private investors and leading industry executives. For more information, please visit http://www.rodm.com

Aegis Capital 2014 Healthcare and Technology Conference
Robert Brooke, CEO, will present a corporate overview of the company at the 2014 Aegis Capital Healthcare and Technology Conference, taking place September 10-13 at The Encore at Wynn in Las Vegas, Nevada. The presentation will be held on Thursday, September 11th in Chopin 3 at 9:00 AM PT.

The Aegis Capital Healthcare & Technology Conference provides a forum to introduce small-cap companies in the life sciences and technology sectors to the investment community. This invitation-only event attracts a wide array of research analysts, fund managers, qualified high net worth individuals and financial advisors seeking compelling ideas for their portfolios. The event will feature company presentations, networking receptions and 1-on-1 investor meetings. For more information, please visit http://www.aegiscapcorp.com

About Stevia First Corp. (OTCQB: STVF)
Stevia First Corp. is an agricultural biotechnology company that has developed expertise for the production of stevia using fermentation and for improvement of traditional stevia farming and processing methods. The Company is also applying breakthrough technologies in software and the life sciences to develop product applications far beyond stevia and the food and beverage industry. For more information visit: www.steviafirst.com. 

About the Stevia Industry
The market for all-natural, zero-calorie stevia sweeteners is expanding rapidly. The World Health Organization (WHO) estimates stevia intake could eventually replace 20-30% of all dietary sweeteners. The total global sweetener market was estimated at $58.3 billion in 2010. For more information visit: www.steviafirst.com. 

Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, projections of worldwide sales of stevia products, growth of stevia production and global markets. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.